Insights
Foley In Fashion
Foley FAB Launches The Laws of Fashion: What’s Trending in 2025
Our team is committed to staying ahead of the curve – our The Laws of Fashion: What’s Trending in 2025 dives deep into the latest case law, highlights key cases to watch, and provides insights into impactful trends and emerging challenges. We have crafted this guide to help you navigate both the opportunities and uncertainties that lie ahead.
Labor & Employment Law Perspectives
From the Pickup Line to the Picket Line: What Employers Need to Know About the Gig Economy Labor Movement
The gig economy has emerged as a defining aspect of the modern workforce, transforming how people work, earn, and engage with employers.
Health Care Law Today
Massachusetts: Expansion of Oversight Authority — New Notice of Material Change Form for Health Care Transactions
The Massachusetts Health Policy Commission, an independent state agency that works to improve affordability of health care for residents of the Commonwealth, released Advance Guidance for “Providers” and “Provider Organizations” considering transactions subject to the HPC’s updated Notice of Material Change process.
Search Insights
Featured Insights
31 March 2025
Foley In Fashion
Foley FAB Launches The Laws of Fashion: What’s Trending in 2025
Our team is committed to staying ahead of the curve – our The Laws of Fashion: What’s Trending in 2025 dives deep into the latest case law, highlights key cases to watch, and provides insights into impactful trends and emerging challenges. We have crafted this guide to help you navigate both the opportunities and uncertainties that lie ahead.
24 March 2025
Labor & Employment Law Perspectives
Trump Executive Order Affects Federal Contractor Minimum Wage
On March 14, 2025, the President issued a new executive order entitled, “Additional Rescissions of Harmful Executive Orders and Actions.”
12 March 2025
Health Care Law Today
GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs
GLP-1 receptor agonists were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management (e.g., Wegovy®) and are now being explored for treating a wide range of health conditions.
Upcoming Events
27 April 2025
Events
Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value
Foley partner Kinal Patel is speaking at the 2025 National Proton Conference in a panel titled “Innovative Payment Strategies in Proton Therapy: Addressing Challenges and Driving Value” on April 27.
30 April 2025
Events
Private Equity and Health Care – A Policy Discussion
Foley partner Larry Vernaglia, co-chair of the firm’s Providers of Health Care Services Area of Focus, and senior counsel Allie Shalom, co-chair of the firm’s Payor/Provider Convergence Area of Focus, are speaking in Healthcare Financial Management Association’s upcoming webinar titled “Private Equity and Health Care – A Policy Discussion” on April 30.
03 May 2025
Events
American Telemedicine Association Nexus 2025
Foley is proud to continue its sponsorship of the American Telemedicine Association (ATA) to offer a plethora of industry insights with attendees during ATA Nexus 2025, exploring The Next Chapter in Virtual Care.
Latest Blog Posts
02 April 2025
Health Care Law Today
GLP-1 Receptor Agonists: Drug Litigation Overview and Trends
The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation involving this class of drugs.
02 April 2025
Health Care Law Today
Texas Court Vacates FDA’s Laboratory Developed Test (LDT) Final Rule
A Texas judge for the U.S. District Court for the Eastern District of Texas issued a ruling on March 31, 2025, to vacate and set aside, in its entirety, the U.S. Food and Drug Administration’s (FDA) Final Rule titled Medical Devices; Laboratory Developed Tests (LDTs)
01 April 2025
Foley Ignite
The Dealmaking Slowdown: A Time for Startups to Prepare
As the slowdown in dealmaking continues, both buyers and sellers are left to consider their options moving forward during this period of extreme uncertainty and market volatility.
Latest Podcast Episodes
20 February 2025
The Path & The Practice
Podcast Episode 123: William McKenna, Partner
This episode of The Path & The Practice features a conversation with William McKenna. Bill is a litigation partner in Foley’s Chicago office.
28 January 2025
The Path & The Practice
Podcast Episode 122: Andrew Wronski, Partner
This episode of The Path & The Practice features a conversation with Andrew Wronski. Andy is a litigation partner in Foley’s Milwaukee office where he is also the office managing partner.
24 January 2025
The Path & The Practice
Podcast Episode 120: Akshay Verma, COO (Spotdraft)
This episode of The Path & The Practice features a conversation with special guest Akshay Verma. Akshay is COO at Spotdraft.
Latest White Papers
11 December 2024
Health Care Law Today
Antibody Drug Conjugates Keep Growing: What You Need to Know
Since 2018, licensing deals totaling over $60 billion have been signed regarding Antibody Drug Conjugates (ADCs), with 2023 alone having at least 18 deals.
16 May 2024
White Papers
The Laws of Fashion: What's Trending in 2024
As we make further strides into 2024, the fashion, apparel & beauty landscape continues its dynamic evolution, marked by opportunities and challenges.
29 April 2024
Health Care Law Today
2024 Health Care & Life Sciences Top Trends
Foley & Lardner’s 2024 Health Care & Life Sciences Top Trends publication unpacks fast-moving developments to help your business.
Latest Viewpoints
02 April 2025
Foley Viewpoints
SEC Climate Disclosures Rules One Step Closer to the Grave; GHG Emissions Disclosures One Step Closer to Becoming a Multi-State Compliance Issue
The slow death of the Securities and Exchange Commission’s (SEC) climate disclosure rules continued on March 27, 2025, with the SEC Commissioners voting to discontinue the defense of such rules before the Eighth Circuit, Iowa v. SEC, No. 24-1522, which is where the numerous complaints challenging the rules were consolidated.
02 April 2025
Foley Viewpoints
Federal Judge Restrains Liability for Alleged False DEI Certifications
President Trump’s January 21 Executive Order targeting Diversity, Equity, and Inclusion Programs and, specifically, § 3(b)(iv)) cannot be the basis for liability — at least for one proactive litigant in the Northern District of Illinois. The holding could have broader implications for False Claims Act defendants concerned about evolving certification requirements.
01 April 2025
Foley Viewpoints
Updated SEC Marketing Rule FAQ: Clarification Regarding Presentation of Net Extracted Performance
On March 19, 2025, the Securities and Exchange Commission staff issued an update to its frequently asked questions guidance with respect to registered investment advisers’ compliance with Rule 206(4)-1 under the Investment Advisers Act of 1940